8-K filed May 7, 2026, 7:59 PM ET ticker GEN CIK 0000849399

earnings confidence high sentiment positive materiality 0.80

Gen Digital FY26 revenue tops $5B, up 27%; raises FY27 guidance; announces $50M restructuring

Gen Digital Inc.

FY26 GAAP revenue $5,000M (+27% YoY); diluted EPS $1.57 (+53%); non-GAAP diluted EPS $2.56 (+15%).
Q4 revenue $1,283M (+27%); Q4 non-GAAP diluted EPS $0.67 (+14%), exceeding guidance.
FY27 non-GAAP guidance raised: revenue $5,325M-$5,425M, EPS $2.85-$2.95.
Board approved $50M restructuring program over next 12 months to streamline ops and adopt AI.
Quarterly dividend of $0.125/share declared, payable June 10, 2026 to holders of record May 18.

item 2.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000849399-26-000014
form_type: 8-K
ticker: GEN
cik: 0000849399
company_name: Gen Digital Inc.
filed_at: 2026-05-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:33.818269+00:00
generated_at: 2026-05-14T22:20:45.974870+00:00
sec_items: ["2.02", "8.01", "9.01"]
event_type: earnings
sentiment: positive
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000849399-26-000014
json_url: https://secwatch.observer/filing/0000849399-26-000014.json
markdown_url: https://secwatch.observer/filing/0000849399-26-000014.md
text_url: https://secwatch.observer/filing/0000849399-26-000014.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/849399/000084939926000014/0000849399-26-000014-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/849399/000084939926000014/nlok-20260507.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

c92d9f979df13e56efb14e7747b4ca7321b3a7c0

Gen Digital Inc. reported the fiscal year ended April 3, 2026 results: revenue $5,000 million, EPS $1.57. Guidance raised.

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

SEC 8-K Item 2.02 confidence 0.9 SEC evidence

da8cf366d0afd5ba2a642f593b2b59fb7a8be24c

Gen Digital Inc. updated its the fiscal year 2026 fourth quarter and full year, which ended April 3, 2026 guidance (raised).

Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital Freedom, released its results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026.

SEC 8-K Item 2.02 confidence 0.95 SEC evidence

Comparable filings

LQDA

Liquidia Q1 2026 net income $53M vs $38M loss YoY; YUTREPIA sales $130M

Liquidia Corp May 11, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 same event type: earnings similar materiality

This filing

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

Comparable filing

First Quarter 2026 Financial Results YUTREPIA sales led to the company’s third consecutive quarter of profitability with net income of $52.9 million and positive non-GAAP adjusted EBITDA of $71.2 million in the first quarter of 2026. Cash and cash equivalents totaled $222.8 million as of March 31, 2026, compared to $190.7 million as of December 31, 2025. Product sales, net, were $129.9 million for the three months ended March 31, 2026.

Filing page SEC filing

LXEO

Lexeo Therapeutics Q1 net loss $20.2M; cash $227.6M; LX2006 pivotal trial protocol submitted to FDA

Lexeo Therapeutics, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 same event type: earnings similar materiality

This filing

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

Comparable filing

Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights

Filing page SEC filing

CRON

Cronos Q1 net revenue up 40% to $45.2M; authorizes $50M share buyback; CanAdelaar close extended to Sep 9

Cronos Group Inc. May 11, 2026, 7:59 PM ET earnings Items 1.01, 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 same event type: earnings similar materiality

This filing

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

Comparable filing

reference in such a filing or document. --- EX-99.1 (EX-99.1) --- Cronos Group Reports 2026 First Quarter Results Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter of record net revenue in Israel, where PEACE

Filing page SEC filing

CERT

Certara Q1 revenue $106.9M (+1%), net loss $8.8M; divests Regulatory Writing for $85M cash

Certara, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 same event type: earnings similar materiality

This filing

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

Comparable filing

First Quarter 2026 Results Total revenue for the first quarter of 2026 was $106.9 million, representing year-over-year growth of 1% on a reported basis. Software revenue for the first quarter of 2026 was $49.7 million, representing year-over-year growth of 7% on a reported basis. Services revenue for the first quarter of 2026 was $57.2 million, representing a year-over-year decrease of 4% on a reported basis . Total Bookings for the first quarter of 2026 were $115.3 million, representing a year-over-year decrease of 2%. Software Bookings for the first quarter of 2026 were $48.7 million, representing a year-over-year increase of 20%. The increase in software bookings was attributable to strong customer demand across our platform. Services Bookings for the first quarter of 2026 were $66.6 million, representing a year-over-year decrease of 14%. The decrease in services bookings was primarily driven by the timing of contract recognition and execution. Total cost of revenues for the first q

Filing page SEC filing

CRCL

Circle Q1 revenue +20% to $694M; announces $222M ARC token presale

Circle Internet Group, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 same event type: earnings similar materiality

This filing

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

Comparable filing

USDC in circulation of $77.0 billion at quarter end grew 28%; USDC onchain transaction volume in Q1’26 of $21.5 trillion grew 263% ● Total revenue and reserve income in Q1’26 of $694 million grew 20% ● Net income from continuing operations in Q1’26 of $55 million decreased 15% ● Adjusted EBITDA in Q1’26 of $151 million grew 24% Business Highlights ● ARC Token: $222M

Filing page SEC filing

ASIX

AdvanSix Q1 net loss $15.5M; sales up 7% to $404M; declares $0.16 dividend; appoints new CFO

AdvanSix Inc. May 8, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 same event type: earnings similar materiality

This filing

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

Comparable filing

the second quarter." Summary first quarter 2026 financial results for the Company are included below: 1 ( $ in Thousands, Except Earnings Per Share) 1Q 2026 1Q 2025 (1) Sales $404,183 $377,791 Net Income (loss) (15,546) 23,344 Diluted Earnings Per Share (0.58) 0.86 Adjusted Diluted Earnings Per Share (2) (0.50) 0.93 Adjusted EBITDA (2) 4,756 51,626 Adjusted

Filing page SEC filing

VSCO

Victoria's Secret Q1 sales up 15% to $1.56B, beats guidance; raises FY2026 outlook

Victoria's Secret & Co. June 2, 2026, 7:01 AM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

Comparable filing

The Company reported net sales of $1.560 billion for the first quarter of 2026, an increase of 15% compared to net sales of $1.353 billion for the first quarter of 2025 and above the previously communicated guidance range of $1.490 billion to $1.525 billion. Total comparable sales for the first quarter of 2026 increased 13%. The Company reported operating income for the first quarter of 2026 of $76 million compared to operating income of $20 million in the first quarter of 2025. Net income was $48 million, or $0.56 per diluted share, for the first quarter of 2026 compared to net loss of $2 million, or $0.02 per diluted share, for the first quarter of 2025.

Filing page SEC filing

SIG

Signet Q1 sales $1.6B, SSS +1.8%; raises FY27 adjusted EPS guidance

SIGNET JEWELERS LTD June 2, 2026, 6:54 AM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

results for fiscal year 2026 fourth quarter and full year, which ended April 3, 2026. "FY26 was a defining year for Gen, our strongest results in a decade, with revenue crossing $5 billion for the first time," said Vincent Pilette, CEO of Gen. "Our guidance proves that we are even more confident today that cyber safety and financial wellness belong together as we

Comparable filing

On June 2, 2026, Signet Jewelers Limited (the "Company") issued a press release announcing results for the first quarter ended May 2, 2026.

Filing page SEC filing

Source: SEC EDGAR

accession 0000849399-26-000014

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.